Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

Specimen Handling 640pembrolizumab 570Magnetic Resonance Spectroscopy 550Carboplatin 430Cyclophosphamide 382Cisplatin 376Biopsy 364Paclitaxel 312Nivolumab 310Gemcitabine 302Radiotherapy 275Bevacizumab 243Dexamethasone 213fludarabine 209Docetaxel 193durvalumab 182atezolizumab 179Oxaliplatin 173Rituximab 168Fluorouracil 168venetoclax 167Pemetrexed 165Doxorubicin 163Radiation 161Capecitabine 161Radiosurgery 149Etoposide 138Ipilimumab 136Leucovorin 134Lenalidomide 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
small molecule inhibitor THX-B × 90 days × Clear all
NCT05694715 2026-03-17

Combination Therapy in Cancers With Mutations in DNA Repair Genes

University of California, San Francisco

Phase 1 Recruiting
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡